Search research articles
Contact Us
Filters
Showing results (171-180 of 337) with videos related to
Page
of 34
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 30, 2016
CTLA-4 Limits Anti-CD20-Mediated Tumor Regression
Zhenhua Ren, Jingya Guo, Jing Liao, et al.
The Journal of Clinical Investigation
|
April 3, 2008
Gadd45beta promotes hepatocyte survival during liver regeneration in mice by modulating JNK signaling
Salvatore Papa, Francesca Zazzeroni, Yang-Xin Fu, et al.
Science (New York, N.Y.)
|
April 14, 2007
Lymphotoxin beta receptor-dependent control of lipid homeostasis
James C Lo, Yugang Wang, Alexei V Tumanov, et al.
Science Immunology
|
January 7, 2022
A tumor-specific pro-IL-12 activates preexisting cytotoxic T cells to control established tumors
Diyuan Xue, Benjamin Moon, Jing Liao, et al.
Gut
|
October 31, 2022
Engineered anti-PDL1 with IFNα targets both immunoinhibitory and activating signals in the liver to break HBV immune tolerance
Chao-Yang Meng, Shiyu Sun, Yong Liang, et al.
Science Translational Medicine
|
August 5, 2021
Dual targeting of CTLA-4 and CD47 on T<sub>reg</sub> cells promotes immunity against solid tumors
Anli Zhang, Zhenhua Ren, Kuo-Fu Tseng, et al.
Cancer Research
|
February 9, 2011
The efficacy of radiotherapy relies upon induction of type i interferon-dependent innate and adaptive immunity
Byron C Burnette, Hua Liang, Youjin Lee, et al.
Nature Biomedical Engineering
|
November 2, 2021
Rejuvenation of tumour-specific T cells through bispecific antibodies targeting PD-L1 on dendritic cells
Longchao Liu, Jiahui Chen, Joonbeom Bae, et al.
Nature Communications
|
July 9, 2024
Metabolic reprograming mediated by tumor cell-intrinsic type I IFN signaling is required for CD47-SIRPα blockade efficacy
Hang Zhou, Wenjun Wang, Hairong Xu, et al.
Cancer Immunology Research
|
May 24, 2017
Converting Lymphoma Cells into Potent Antigen-Presenting Cells for Interferon-Induced Tumor Regression
Jing Liao, Yan Luan, Zhenhua Ren, et al.
Page
of 34
Search research articles
Search
Showing results (171-180 of 337) with videos related to
Sort By:
Page
of 34
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 30, 2016
CTLA-4 Limits Anti-CD20-Mediated Tumor Regression
Zhenhua Ren, Jingya Guo, Jing Liao, et al.
The Journal of Clinical Investigation
|
April 3, 2008
Gadd45beta promotes hepatocyte survival during liver regeneration in mice by modulating JNK signaling
Salvatore Papa, Francesca Zazzeroni, Yang-Xin Fu, et al.
Science (New York, N.Y.)
|
April 14, 2007
Lymphotoxin beta receptor-dependent control of lipid homeostasis
James C Lo, Yugang Wang, Alexei V Tumanov, et al.
Science Immunology
|
January 7, 2022
A tumor-specific pro-IL-12 activates preexisting cytotoxic T cells to control established tumors
Diyuan Xue, Benjamin Moon, Jing Liao, et al.
Gut
|
October 31, 2022
Engineered anti-PDL1 with IFNα targets both immunoinhibitory and activating signals in the liver to break HBV immune tolerance
Chao-Yang Meng, Shiyu Sun, Yong Liang, et al.
Science Translational Medicine
|
August 5, 2021
Dual targeting of CTLA-4 and CD47 on T<sub>reg</sub> cells promotes immunity against solid tumors
Anli Zhang, Zhenhua Ren, Kuo-Fu Tseng, et al.
Cancer Research
|
February 9, 2011
The efficacy of radiotherapy relies upon induction of type i interferon-dependent innate and adaptive immunity
Byron C Burnette, Hua Liang, Youjin Lee, et al.
Nature Biomedical Engineering
|
November 2, 2021
Rejuvenation of tumour-specific T cells through bispecific antibodies targeting PD-L1 on dendritic cells
Longchao Liu, Jiahui Chen, Joonbeom Bae, et al.
Nature Communications
|
July 9, 2024
Metabolic reprograming mediated by tumor cell-intrinsic type I IFN signaling is required for CD47-SIRPα blockade efficacy
Hang Zhou, Wenjun Wang, Hairong Xu, et al.
Cancer Immunology Research
|
May 24, 2017
Converting Lymphoma Cells into Potent Antigen-Presenting Cells for Interferon-Induced Tumor Regression
Jing Liao, Yan Luan, Zhenhua Ren, et al.
Page
of 34